|
|
|
|
Vol. 17, Issue 6, 2811-2823, June 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



*Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Ludwig-Maximilians-Universität, 80336 Munich, Germany;
Medizinische Klinik IV, Universität Tübingen, 72076 Tübingen, Germany;
Institut für Infektionsmedizin, Universitätsklinikum Hamburg Epppendorf, 20246 Hamburg, Germany;
Institut für Zellbiologie, Ludwig-Maximilians-Universität, 80336 Munich, Germany; ||Max-Planck-Institut für Infektionsbiologie, 10117 Berlin, Germany; and ¶Institut für Molekular- und Zellphysiologie, Medizinische Hochschule Hannover, 30625 Hannover, Germany
Submitted November 3, 2005;
Revised February 24, 2006;
Accepted March 9, 2006
Monitoring Editor: Paul Matsudaira
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Podosomes are actin-rich adhesions typical for cells of the monocytic lineage, but they are also formed in other cell types (reviewed in Linder and Aepfelbacher, 2003
; Buccione et al., 2004
). Prominent features that distinguish podosomes (and the related invadopodia) from other adhesions are their two-part architecturea core of F-actin and associated proteins embedded in a ring structure containing plaque proteins such as paxillin or vinculinand their ability to concentrate matrix metalloproteases and actively engage in matrix degradation (reviewed in Linder and Kopp, 2005
). Podosomes are thought to play important roles in migration and invasion of cells. Podosome-mediated adhesion provides local anchorage and may thus stabilize cellular protrusions and support directional migration. Importantly, podosome-localized release of matrix metalloproteases probably contributes to the invasive abilities of podosome-forming cells in physiological and pathological conditions.
Podosomes are highly dynamic organelles with a lifetime of 212 min (Kanehisa et al., 1990
; Destaing et al., 2003
), and their regulation comprises multiple signal transduction pathways, including Src kinase activity (Marchisio et al., 1988
) as well as RhoGTPase signaling and actin-regulatory mechanisms (Linder et al., 1999
; Burns et al., 2001
). Importantly, microtubules have been shown to influence the dynamics (Evans et al., 2003
), positioning (Babb et al., 1997
; Destaing et al., 2005
), and formation (Linder et al., 2000
) of podosomes. However, despite the observed close association of podosomes and microtubules, it remained unclear whether both structures indeed interact in living cells. Moreover, the molecular basis for this functional dependency remained unresolved.
Here, we show that the kinesin kinesin-like-family (KIF)1C, a member of Kinesin-3 family (Linder et al., 2000
), is critically involved in the microtubule-dependent regulation of podosome dynamics in macrophages. KIF1C has been implicated in Golgiendoplasmic reticulum (ER) transport (Dorner et al., 1998
) and in mouse macrophage resistance to anthrax toxin (Watters et al., 2001
). Knockout experiments in mice, however, suggested that KIF1C activity is dispensable for GolgiER transport (Nakajima et al., 2002
). So far, no function for KIF1C has been described in human cells.
We now show that KIF1C is enriched at a subset of microtubule plus ends that contact podosomes. Contact by KIF1C is followed by enhanced podosome dynamics, i.e., fission or dissolution. Conversely, expression of mutation or truncation constructs of KIF1C resulted in decreased podosome dynamics and ultimately in podosome deficiency. We further identify nonmuscle myosin IIA as an interaction partner of KIF1C. Myosin IIA is enriched in regions of high podosome turnover, and its binding to KIF1C may contribute to the efficient targeting of podosomes by microtubule plus ends.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Microinjection of Proteins
Cells for microinjection experiments were cultured for 58 d. Proteins were expressed in Escherichia coli, as described previously (Linder et al., 2000
). For microinjection, proteins were dialyzed against microinjection buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 5 mM MgCl2), concentrated in Centricon filters (Millipore, Bedford, MA), shock-frozen, and stored at 80°C. Microinjection was performed using transjector 5246 (Eppendorf, Hamburg, Germany) and a Compic Inject micromanipulator (Cell Biology Trading, Hamburg, Germany). Glutathione S-transferase (GST)-KIF1C-protein tyrosine phosphatase-binding domain (PBD) was injected into the cytoplasm at 1, 2, and 3 µg/µl. (Inhibitory) antibodies m74-2, SUK4 (Cytoskeleton, Denver, CO) and K2.4 (HiSS Diagnostics, Freiburg, Germany) against dynein heavy chain, KIF5B or KIF3B, respectively, were injected at 4 or 5 µg/µl (K2.4). Control experiments were performed with GST or microinjection buffer. Injected cells were identified by labeling coinjected rat IgG (5 mg/ml; Dianova, Hamburg, Germany) with fluorescein isothiocyanate-labeled goat anti-rat IgG antibody (Dianova).
Transfection of Cells
Cells were transiently transfected using a Nucleofector I (amaxa, Köln, Germany) according to the manufacturer's instructions and seeded on coverslips at a density of 5 x 105.
Immunofluorescence and Microscopy
Cells were fixed for 10 min in 3.7% formaldehyde solution and permeabilized for 1 min in ice-cold acetone. F-actin was stained with Alexa 568-labeled phalloidin (Molecular Probes, Leiden, The Netherlands), KIF1C was stained with specific primary antibody (Ab) (Cytoskeleton), mitochondria were stained with OxPhos-Ab against cytochrome-c oxidase subunit I (Molecular Probes), myosin IIA was stained with specific primary polyclonal Ab (DakoCytomation Denmark, Glostrup, Denmark), and tubulin was stained with specific primary polyclonal Ab (Cytoskeleton; Note: This antibody also works sufficiently with formaldehyde fixation, which was used when costaining of other proteins in tubulin-specific fixations such as glutaraldehyde/PHEM was not feasible.) Secondary antibodies were Alexa 488- or Alexa 568-labeled goat anti-mouse, goat anti-rabbit, or goat anti-sheep (Molecular Probes). Coverslips were mounted in Mowiol (Calbiochem, Darmstadt, Germany) containing p-phenylendiamine (Sigma-Aldrich, St. Louis, MO) as antifading reagent and sealed with nail polish.
Microscopy was performed as described previously (Linder et al., 2000
). Immunofluorescence-stained preparations were observed with a Leica DM RBE microscope using a 100x plan fluotar objective. Images were captured with a Spot-camera (Leica, Wetzlar, Germany). Confocal microscopy was performed with a Leica DM IRB confocal scanning microscope and a 100x plan apo objective.
Live Cell Imaging
Confocal time-lapse microscopy of transiently transfected cells was performed using an UltraView LCI live cell imaging system with UltraView, version 5.5.0.2
[EC]
(PerkinElmer Life and Analytical Sciences, Boston, MA), images were captured using a scan interline digital charge-coupled device camera, model Orca ER (Hamamatsu, Herrsching, Germany) with a resolution of 1344 x 1024 pixels and converted to 12-bit-images. Filter settings were 488-nm excitation, 525/50-nm emission, 568-nm excitation, and 697/45-nm emission. Cells were seeded on glass-bottomed dishes (MatTek, Ashland, MA) at a density of 48 x 105 and incubated 20 h before the start of the experiment. During the experiment, cells were incubated in a chamber connected to an incubator controller (EMBL, Heidelberg, Germany) at 37°C and 5% CO2.
To be scored as a contact between podosomes (labeled with monomeric red fluorescent protein [mRFP]-actin) and microtubule plus ends (labeled with green fluorescent protein [GFP]-cytoplasmic linker protein [CLIP]170 or KIF1C-GFP), the respective mRFP and GFP signals had to be directly adjacent or overlapping, without intermediate black pixels. Contact in most cases included 1) apparently directed, not random, movement of plus ends toward podosomes, 2) a momentary stop of movement at podosomes, and 3) a subsequent change or reversal of direction. A correlation between microtubule contact and podosome fate was scored if an alteration of podosome behavior (fission or dissolution) was discernible within 12 min after contact by a microtubule plus end (most alterations were observed within shorter periods).
Plasmid Construction and Mutagenesis
For cloning of GST-KIF1C-P, part of the coding sequence of human KIF1C was amplified and cloned into pGEX-1
T, resulting in a construct coding for aa 713-811. For cloning and expression of GST-KIF1C-U, the coding sequence of KIF1C was amplified and cloned into pGEX5X-3, resulting in a construct coding for aa 441-623. For cloning and expression of wild-type GFP-KIF1C, the 5' half of the coding sequence up to nucleotide 1847 was amplified from pRKS-KIF1C generating a 5'XhoI and a 3'EcoRI restriction site. The 3' half of the KIF1C coding sequence was amplified generating a 5'EcoRI and a 3'BamHI restriction site. The two regions were cloned successively into vector pEGFP-N1 (Clontech, Mountain View, CA). GFP-KIF1C-K103A was generated by removing the newly generated EcoRI restriction site and by introducing a K103A mutation using QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA).
Vector encoding GFP-KIF3B
NT was a kind gift from V. Gelfand (University of Illinois, Urbana, IL); MBP-kinesin-associated protein (KAP)3 was a kind gift from Y. Takai (Osaka University, Osaka, Japan); GFP-KAP3-wild type (wt) and GFP-KAP3
Arm5 were kind gifts from T. Akiyama (University of Tokyo, Tokyo, Japan); KIF4 was a kind gift from Y. Lee (Ajou University, Suwon, South Korea); Myc-KHC wt, Myc-KHC H582, HA-kinesin light chain (KLC) wt, HA-KLC-TPR6, and HA-KLC-L176 were kind gifts from B. Schnapp (Harvard Medical School, Boston, MA); FLAG-KLC2 was a kind gift from T. Ichimura (Tokyo Metropolitan University, Tokyo, Japan); DsRed-EB1 was a kind gift from A. Barth (Stanford University, Stanford, CA); and GFP-CLIP170 was a kind gift from N. Galjart (Erasmus Medical Center, Rotterdam, The Netherlands).
GST-Pull Down Assay
GST-pull downs were prepared as described previously (Linder et al., 1999
). Briefly, 12 x 106 cells cultured for 612 d were lysed by addition of 1.2 ml of lysis buffer (10 mM Tris-HCl, pH 8, 1% Triton X-100, 75 mM NaCl, 5 mM EDTA, and 1 mM dithiothreitol), containing Complete mini protease inhibitors (Roche Diagnostics, Penzberg, Germany) and incubated for 30 min at 4°C. After centrifugation at 3500 x g for 10 min at 4°C, the lysate was added to glutathione-Sepharose beads (GE Healthcare, München, Germany), previously incubated with 150 µg of GST-fusion proteins or GST at comparable molar ratios. Beads were incubated with lysate for 1 h at 4°C, washed three times with lysis buffer, pelleted, and mixed with 100 µl of SDS-sample buffer.
Immunoblotting
Immunolabeling was performed by standard procedure, using the above-mentioned primary antibodies. Secondary antibodies were horseradish peroxidase-coupled anti-mouse or anti-rabbit IgG (Dianova). Protein bands were visualized by using Super Signal kit (Pierce Chemical, Rockford, IL) and X-Omat AR film (Kodak, Stuttgart, Germany).
Validation of Small Interfering RNA by Quantitative Real-Time PCR
Small interfering RNAs (siRNAs) were validated by quantitative real-time PCR (q-PCR) using lysates of transfected HeLa cells, as described previously (Machuy et al., 2005
). Briefly, 0.10.25 µg of siRNA (final concentration, 80200 nM) directed against KIF1C, KIF3A, KAP3A, KIF5B, or Luciferase as control and 2 µl Transmessenger reagent (QIAGEN, Hilden, Germany) were added to 10 x 104 cells seeded in 96-well plates. RNA was isolated 48 h later using the RNeasy 96 BioRobot 8000 system (QIAGEN). The relative amount of target mRNA was determined by q-PCR using Quantitect SYBR Green reverse transcriptase-PCR kit following manufacturer's instructions (QIAGEN).
siRNA/Short Hairpin RNA Knockdown Experiments
Duplex siRNA (650 ng) was transfected transiently in primary human macrophages. For visualization of transfected cells, 1.2 µg of pEGFP-N1-vector was cotransfected, and cells were cultured for 2472 h. For vector-encoded short hairpin RNA (shRNA), different target regions in the KIF1C coding sequence were chosen and cloned into psiSTRIKE U6 (Promega, Madison, WI). Cells were transfected and cultured for additional 2472 h. Target sequence corresponds to the nucleotides 426442 in KIF1C. As a control, a scrambled sequence was used.
Reverse Transcriptase Reaction
Cells (6 x 106) were cultured for 7 d, and mRNA was isolated using QuickPrep Micro-mRNA purification kit (GE Healthcare). DNA was removed by DNAse digestion (Novagen, Madison, WI). For cDNA-synthesis, 1 µg of random primer (Promega) was annealed to 2 µg of RNA for 5 min at 70°C, and second strand synthesis was performed using Moloney murine leukemia virus reverse transcriptase (Promega) using an oligonucleotide primer pair corresponding to nucleotides 30303059 and 33693397 of the KIF1C coding sequence, respectively. As a control for quantitative removal of residual DNA, oligonucleotide primers specific for an exon in the human
-actin gene were used, corresponding to nucleotides 11611142 and 716735, respectively.
Podosome Reformation
Podosomes were disrupted by addition of tyrosine kinase inhibitor PP2 (Sigma-Aldrich) at 25 µM for 1 h with subsequent washout. Podosome disruption/reformation does not interfere with microtubule integrity or distribution (Linder et al., 2000
). Macrophages normally display 50150 podosomes per cell. The threshold value for a macrophage containing podosomes was set to 10. This allowed an immediate and clear distinction between cells "containing" or "not containing" podosomes.
Immunoprecipitation
Immunoprecipitations were performed with the µMACS-protein isolation kit (Miltenyi Biotec, Bergisch-Gladbach, Germany). Seven- to 14-d-old macrophages were lysed in lysis buffer A (50 mM Tris-HCl, pH 7.5, 100 mM KCl, and 0.5% Triton X-100) or B (20 mM HEPES, pH 7.5, 150 mM NaCl, 250 mM sucrose, 1 mM Na-molybdate, and 1% Igepal), both with Complete protease inhibitors (Roche Diagnostics). Two micrograms of antibody was added to 50 µl of protein A-coupled magnetic beads, incubated with the cleared lysate for 1 h, and applied to the µMACS separation column. After washing four times with washing buffer (20 mM HEPES, 150 mM NaCl, 2 mM peroxovanadate, 0,1% Triton X-100, and 10% glycerol), the immunoprecipitate was eluted with 1x Laemmli buffer. Immunoprecipitations of GFP fusion proteins were performed using the GFP-µMACS epitope tag Protein isolation kit (Miltenyi Biotec) according to the manufacturer's protocol. The cells were lysed in (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, and 1% Igepal), with Complete Mini protease inhibitors.
Mass Spectrometry
Silver-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel bands were washed twice with water and then covered with a 1:1 mixture of 30 mM potassium ferricyanide and 100 mM sodium thiosulfate and washed twice with water. Clear gel pieces were then treated twice with 50% acetonitrile for 5 min. Trypsin (sequencing grade modified; Promega, Mannheim, Germany) was added, and proteins were digested overnight in 40 mM NH4HCO3 buffer, pH 8.0, at 37°C and 650 rpm. For protein identification, probes were used for matrix-assisted laser desorption ionization/time of flight (MALDI-TOF) experiments. Ten microliters of each sample was first purified and concentrated on a C18 reverse phase pipette tip (ZipTip; Millipore, Schwalbach, Germany). Peptides were eluted with 1 µl of
-cyano-4-hydroxycinnamic acid (Sigma-Aldrich) and directly spotted on a MALDI sample plate (Applied Biosystems, Foster City, CA). MALDI-TOF measurements were performed on a Voyager-DE STR TOF mass spectrometer (Applied Biosystems). The resulting spectra were then analyzed via Mascot software (Matrix Science, London, United Kingdom) using the NCBInr Protein Databank.
Microtubule Cosedimentation Assay
Cells (1.2 x 107) were lysed in (80 mM PIPES, pH 6.8, 1 mM MgCl2, and 1 mM EGTA, with protease inhibitors) and centrifuged at 100 000 x g for 1 h. Tubulin in the cytosol was polymerized by addition of (2 mM GTP, 2 mM MgCl2, and 20 µM taxol, end concentrations), and motor proteins were allowed to bind for 30 min at room temperature in the presence of 1.5 mM adenyl-5'-yl imidodiphosphate (AMP-PNP). Motortubulin complexes were pelleted by centrifugation at 165 000 x g for 1 h, and aliquots of resuspended pellets were analyzed with SDS-PAGE and Western blots.
| RESULTS |
|---|
|
|
|---|
-actin, to label podosomes, and GFP-fused CLIP170, a microtubule plus endbinding protein (reviewed in Galjart, 2005
|
60%). By contrast, <20% of podosomes were not contacted by microtubules, and the majority of these podosomes (
60%) remained static (Figure 1B; Note: Dynamic podosomes showed the typical life time of 28 min, whereas static podosomes persisted for at least 20 min.) Interestingly, subcellular analysis revealed areas in which one type of podosome behavior prevailed, because dynamic behavior occurred mostly in the outer regions of the cell, whereas static podosomes localized preferentially in the center of the substrate-attached cell side (Figure 1C).
Podosomes Are Influenced by ATP Hydrolysis but Not by KIF5B or Dynein
Contact by microtubules raised the possibility of motor proteins being involved in podosome regulation. To investigate this question, we evaluated podosome reformation under conditions of motor protein inhibition. This assay takes advantage of a microinjection artifact, because injection of macrophages with high pressure leads to disruption of podosomes, which are subsequently reformed within 1 h (with microtubule integrity not being compromised; Linder et al., 2000
). Microinjection with the nonhydrolysable ATP analogue AMP-PNP led to a reduction of
60% in podosome reformation (Figure 2A and Table 1), indicating the general influence of ATP hydrolysis-dependent processes. An antibody (Ingold et al., 1988
) against conventional kinesin (KIF5B in the unified nomenclature; Miki et al., 2001
), which has been shown to inhibit focal adhesion regulation by microtubules in Xenopus fibroblasts (Krylyshkina et al., 2002
), did not influence podosome reformation (Figure 2, AC, and Table 1). However, in an established control assay testing its functionality (Krylyshkina et al., 2002
), the antibody effectively inhibited the plus enddirected transport of mitochondria in macrophages (Supplemental Figure S1). Also, microinjection of a potentially inhibiting antibody against heterotrimeric kinesin (Morris and Scholey, 1997
) did not interfere with podosome reformation (our unpublished data). Moreover, inhibition of dynein, either by an inhibitory antibody (Steffen et al., 1997
) or by the inhibitor erythro-9-[3-(2-hydroxynonyl)]adenine (EHNA; Schliwa et al., 1984
) did not influence podosome reformation (Figure 2A and Table 1), although, in an established functionality assay (Krylyshkina et al., 2002
), both substances inhibited minus enddirected lysosome transport in macrophages (Supplemental Figure S2; our unpublished data). These results indicate that neither conventional kinesin nor dynein are important for the reestablishment of regular podosome dynamics in macrophages.
|
|
In a next step, we synthesized siRNAs against KIF1C, KIF3A, KAP3A, and KIF5B, which were validated in HeLa cells and found to be highly effective (>84.0% knockdown; see Materials and Methods). Primary macrophages were transfected with the respective siRNA and evaluated for podosome content 24 and 48 h after transfection. Cotransfected pEGFP-N1 (at substoichiometric concentrations; see Materials and Methods) served as a transfection marker. Compared with controls, KIF3A-, KAP3A- and KIF5B-specific siRNA showed a slight effect on podosome numbers. By contrast, KIF1C siRNA-transfected macrophages showed a marked and significant reduction in podosome content to
60% of controls (Figure 2E and Table 1).
This was further confirmed by transfection of a construct which allows bicistronic expression of KIF1C-specific shRNA and enhanced green fluorescent protein (EGFP) for unequivocal identification of transfected cells (STRIKE-KIF1C). Test transfection of human umbilical vein endothelial cells (HUVECs) showed efficient reduction of endogenous KIF1C protein expression levels, compared with a construct encoding a scrambled sequence (STRIKE-scrambled; Figure 2F). Primary macrophages transfected with the KIF1C-specific construct showed a (gradual) reduction of podosomes (Supplemental Figure S3A), to levels similar to those of cells directly transfected with siRNA (Figure 2G). In addition, those cells transfected with the KIF1C-specific construct but still containing podosomes showed decreased podosome fission (13.8 ± 7.4% for STRIKE-KIF1C versus 30.6 ± 10.7% for STRIKE-scrambled; Figure 2H). In sum, interference with KIF1C function during podosome reformation either by expression of mutant constructs or through transfection/expression of specific siRNA or shRNA seemed to disrupt regular podosome dynamics and led to increasing numbers of cells devoid of podosomes.
KIF1C Is Enriched at Podosome-contacting Microtubule Plus Ends
To confirm endogenous expression of KIF1C in primary human macrophages, several assays were performed. The presence of KIF1C mRNA in macrophages was confirmed by reverse transcriptase-PCR using specific primers and subsequent sequencing of the PCR product (Figure 3A), whereas Western blots of KIF1C immunoprecipitations, developed with a specific antibody, confirmed expression of the corresponding polypeptide in macrophage lysates (Figure 3B). Moreover, in a microtubule cosedimentation assay, KIF1C was present in the microtubule-containing pellet (Figure 3C), indicating a microtubule-binding ability of the protein. Immunofluorescence analysis of endogenous KIF1C showed an enrichment at the periphery of the ventral cell side (Figure 3, D and F) and also at a juxtanuclear position, which, by staining for
-tubulin, was shown to overlap with the centrosome/MTOC (Figure 3, E and F).
|
-actin. Importantly, expression of KIF1C-GFP did not significantly influence podosome content of cells, compared with controls (Supplemental Figure S3B). KIF1C-GFP was found to accumulate in punctate structures at the podosome-containing ventral cell side and especially at regions of high podosome turnover (Figure 4A; Supplemental Videos 5 and 6). Similar to microtubule plus ends, dot-like KIF1C-GFP accumulations repeatedly contacted podosomes (Figure 4A). Indeed, coexpression of DsRed-labeled EB1, highlighting microtubule plus ends (Louie et al., 2004
-tubulin (Supplemental Figure S4BD).
|
60% of all podosomes were contacted by KIF1C-GFP accumulations (Figure 4C). Compared with GFP-CLIP170labeled microtubule plus ends (
84% contact), these data indicate that only a subset of microtubule plus ends show KIF1C enrichment. Interestingly, KIF1C-decorated microtubule plus ends mostly contact podosomes in the cell periphery (Supplemental Figure S5). Contact of podosomes by this microtubule subset is apparently highly effective in inducing changes in podosome behavior, because
75% of KIF1C-contacted podosomes subsequently dissolved (26 ± 8% of all podosomes) or split (16 ± 4% of all podosomes). Conversely, 25% of KIF1C-GFPcontacted podosomes showed no subsequent change, compared with 50% of the podosomes that were not contacted by KIF1C-GFP (Figure 4C).
Expression of a P-Loop Mutant of KIF1C Leads to Podosome Loss
Typical for kinesins, KIF1C features a P-loop sequence (GQTGAGKS; aa 97-104; Dorner et al., 1998
), which is supposedly involved in nucleotide binding (Sack et al., 1999
). Mutations in the corresponding motif of KIF5B have been shown to abrogate ATP hydrolysis and induce a rigor state (Nakata and Hirokawa, 1995
). Therefore, attempting to generate a dominant negative construct of KIF1C, we introduced a K103A mutation (Figure 5A). Mutant KIF1C-K103A-GFP was mostly dislocalized from microtubule plus ends and instead concentrated at a dot-like juxtanuclear position (Figure 5B), which, by costaining for
-tubulin, was identified as the centrosome/MTOC (our unpublished data). The expression of KIF1C-K103A-GFP led to a clear reduction in cellular podosome content (Figure 5B), without apparently compromising microtubule number, length or dynamics (our unpublished data). Quantifying this phenomenon in the podosome reformation assay, we found that only
45% of KIF1C-K103Aexpressing cells formed podosomes, compared with
75% of control cells (Figure 5C). The inability of KIF1C-K103Aexpressing cells to reform podosomes was clearly coupled to an aberrant localization of the mutant protein, because
80% of cells without podosomes showed an accumulation of KIF1C-K103A at the MTOC, in contrast to
35% of the cells that were still able to form podosomes (Figure 5C).
|
|
200 kDa (Figure 6A), which was identified as nonmuscle myosin IIA. This was confirmed by cross-immunoprecipitation of cell-internal KIF1C and myosin IIA from macrophage lysates under physiological salt conditions (150 mM NaCl; Figure 6B), indicating an interaction between both motors.
|
Inhibition of Nonmuscle Myosin IIA Leads to Podosome Loss
This is further underscored by the fact that both nonmuscle myosin IIA and KIF1C-GFP localize preferentially to the periphery of the ventral cell side in macrophages (Figure 7A). Moreover, inhibition of nonmuscle myosin II (A and B) via the specific inhibitor blebbistatin (Limouze et al., 2004
) resulted in a dose-dependent decrease of podosome-containing cells (Figure 7B). Interestingly, even in cells that still contain podosomes, podosome disruption could be observed in the cell periphery (Figure 7C), where myosin IIA is mostly concentrated (Figure 7A). In this context, it is noteworthy that 1) dynamic podosomes also localize to this region (Figure 1C) and 2) KIF1C-GFPdecorated plus ends preferentially contact podosomes in the cell periphery, whereas GFP-CLIP170decorated microtubule plus ends contact podosomes irrespective of their subcellular localization (see Supplemental Figure S4). In sum, both KIF1C-decorated microtubule plus ends and myosin IIA preferentially localize to the region of dynamic podosomes, and inhibition of either motor protein disrupts podosome turnover.
|
| DISCUSSION |
|---|
|
|
|---|
Our data now show that macrophage podosomes are targeted, sometimes repeatedly, by microtubule plus ends. Interestingly, contacted podosomes, and especially those located in the cell periphery, show a certain tendency toward dynamic behavior, i.e., fission or dissolution. This correlation is not very stringent, but together with previous data showing the overall importance of microtubules for human macrophage podosomes (Linder et al., 2000
), it seems to imply that contact by microtubules may be necessary for podosome regulation, whereas not all contacts are equally productive. Indeed, experiments using nocodazole showed the absolute necessity of microtubules for podosome reformation after disruption, whereas in cells already containing podosomes, microtubules have only an impact of 3040% on the upkeep of these structures. The latter observation may indeed reflect microtubule-dependent fission of podosome precursors leading to the formation of new podosomes.
Overall, these results are reminiscent of work on focal adhesions, which shows that microtubules repeatedly target these structures, thereby inducing their dissolution (Kaverina et al., 1999
; Krylyshkina et al., 2003
). In human macrophages, however, microtubule plus ends influence both dissolution and fission of podosomes, i.e., not only the breakdown but also the generation of podosomes. Ultimately, both events might be based on the same phenomenon, namely, the localized or overall dissolution of the podosome structure. For fission, for example, it could be argued that a dissolution process would have to affect only the connecting structure between future daughter podosomes. However, the factors inducing or even fine-tuning such disruption processes are unknown at the moment.
Surprisingly, and in contrast to previous results showing roughly equal rates of podosome fission and fusion in IC-21 mouse macrophages (Evans et al., 2003
), we could only rarely detect fusion events (<1% of all observed podosomes) in our system. It is not clear why this difference occurs; possible explanations are the use of different species (mouse versus human), the use of a cell line versus primary cells, or the observation of migrating versus quiescent cells. Regardless, this demonstrates that podosome behavior is complex, and specifics may differ in various cell systems.
Contact with microtubules suggested the involvement of microtubule-based motor proteins in podosome regulationa possibility unexplored so far. Initial experiments using microinjection of inhibitory antibodies or inhibitors against conventional kinesin or dynein showed no effect on podosome reformation. This is in clear contrast to the regulation of focal adhesions, where microtubule-dependent disassembly has been shown to involve conventional kinesin (Krylyshkina et al., 2002
). However, we cannot rule out a possible long-term role for dynein in podosome dynamics.
A broader approach, combining overexpression of diverse kinesin constructs and siRNA transfection, led to the identification of KIF1C, a member of the Kinesin-3 family, as a motor protein potentially involved in podosome regulation. The involvement of other kinesins such as heterotrimeric kinesin in this process is possible and even likely. However, in all assays, interference with KIF1C expression or function gave the most consistent and significant results. This evaluation was further confirmed by time-lapse confocal microscopy, which revealed KIF1C accumulations being localized at microtubule plus ends and contacting regions of high podosome turnover. A comparison with CLIP170-labeled plus ends showed that KIF1C was only present at a subset of microtubules, and contact of podosomes with these plus ends was coupled with high percentages of podosomes showing fission or dissolution. Conversely, transfection of KIF1C-specific shRNA or expression of a mutant carrying a point mutation in the P-loop, which has been shown to inactive ATPase activity (Honegger et al., 1987
), led to decreased podosome dynamics and podosome deficiency. Together, these data argue for KIF1C being a microtubule plus endlocalized regulator of podosome dynamics.
In addition to microtubule plus ends, KIF1C also localizes to a region surrounding the MTOC. Although endogenous KIF1C can be found at both locations, the KIF1C P-loop mutant localized preferentially around the MTOC, and this was accompanied by a drastic decrease in podosomes. Interestingly, a rigor mutant of the related KIF1B
shows a similar localization (Honegger et al., 1987
). Rigor mutations may therefore lead to nonprocessive motors that are still able to bind microtubules/minus ends but can no longer move along the filaments to reach the plus ends. In this context, it is also noteworthy that overexpressed KIF1C has been shown to form heterodimers with the endogenous motor (Dorner et al., 1999
). In consequence, functional defects in overexpressed forms of KIF1C, such as the P-loop mutant we used here, probably lead to functional impairment of the endogenous form, resulting in defective regulation of podosomes.
In theory, also KIF1C unassociated to microtubules may have cellular effects. However, at least in the confocal plane of podosomes, KIF1C was almost exclusively associated with microtubules or their plus ends. Moreover, expression of the P-loop mutant, which is only defective in ATP hydrolysis, also results in podosome disruption. Therefore, the movement of KIF1C along microtubules (toward their plus ends) seems to be essential for KIF1C to exert its effect on podosomes.
The search for a potential interaction partner of KIF1C in macrophages led to the identification of nonmuscle myosin IIA. Functional coupling of kinesin and myosin is needed for the coordination of cellular processes such as vesicle transport, for example through binding of both motors to the same cargo vesicle (Schliwa and Woehlke, 2003
). However, kinesins and myosins can also interact directly, as shown for KhcU and MyoVa (Huang et al., 1999
). Here, we show that KIF1C can interact with nonmuscle myosin IIA through its PTPD-binding domain, thus providing an interface between the actin and tubulin cytoskeletons. The possible connection between both motors is underscored by the fact that microinjection of the myosin IIA binding domain of KIF1C, thought to compete with the interaction of both proteins, led to a dose-dependent decrease of podosomes.
Interestingly, myosin IIA is enriched in the cell periphery, where also dynamic podosomes localize, and inhibition of myosin II by blebbistatin leads to loss of podosomes preferentially in this region. Actomyosin-generated force has been shown to regulate the formation and size of focal adhesions, and it has been suggested that microtubules might trigger the dissolution of focal adhesions through the local inhibition of myosin II-dependent contractility (Kaverina et al., 2002
; Bershadsky et al., 2003
). A similar mechanism could be envisaged for podosomes. Alternatively, myosin IIA could also act as a bridging molecule between podosomes and microtubules. Indeed, myosins have been shown to be involved in binding or capturing microtubule plus ends and targeting them to the cell cortex (reviewed in Gundersen et al., 2004
).
Considering previous findings of 1) podosomes being interconnected by a fine meshwork of actin filaments (Gavazzi et al., 1989
), 2) microtubule growth sometimes occurring along actin bundles (Salmon et al., 2002
), and 3) microtubules targeting focal adhesions along established "tracks" (Krylyshkina et al., 2003
), one can speculate that KIF1C binding to myosin IIA could couple microtubule plus ends to podosome-connecting actin cables, thus establishing a "homing mechanism" for microtubules to efficiently target podosomes (Figure 7D). A similar model has been proposed for microtubule targeting of focal adhesions (reviewed in Small et al., 2002
; Rodriguez et al., 2003
). Alternatively, podosome-localized myosin IIA may enable a stabilized, productive contact by microtubules without being directly involved in microtubule targeting per se (Figure 7D). Of course, both alternatives would not be mutually exclusive.
In sum, our data demonstrate that the kinesin KIF1C is a central player in the microtubule-dependent regulation of podosomes and that the KIF1Cmyosin IIA interface may play a role in facilitating podosome dynamics in a subcellularly fine-tuned manner. KIF1C is the first kinesin protein to be implicated in podosome regulation, and conversely, regulation of podosome dynamics is the first function of KIF1C described in human cells. It will be interesting to determine whether KIF1C simply acts as a "tether" for microtubule plus ends or whether it also transports regulatory factors to podosomes. Indeed, it is very likely that further molecules other than KIF1C or myosin IIA are involved in (functionally or physically) linking podosomes and microtubule plus ends. The identification of these factors and of the regulatory signals supposedly being delivered by microtubules are interesting challenges to be solved in future experiments.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
![]()
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org). ![]()
Address correspondence to: Stefan Linder ( stefan.linder{at}med.uni-muenchen.de)
Abbreviations used: AMP-PNP, adenyl-5'-yl imidodiphosphate; CLIP, cytoplasmic linker protein; EHNA, erythro-9-[3-(2-hydroxynonyl)]adenine; KAP, kinesin-associated protein; KIF, kinesin-like-family; KLC, kinesin light chain; MALDI-TOF, matrix-assisted laser desorption ionization/time of flight; mRFP, monomeric red fluorescent protein; MTOC, microtubule-organizing center; PBD, protein tyrosine phosphatase-binding domain; PTPD, protein tyrosine phosphatase; siRNA, small interfering RNA; shRNA, short hairpin RNA
| REFERENCES |
|---|
|
|
|---|
Bershadsky, A., Balaban, N. Q., Geiger, B. (2003). Adhesion-dependent cell mechanosensitivity. Annu. Rev. Cell Dev. Biol 19, 677695.[CrossRef][Medline]
Buccione, R., Orth, J., McNiven, M. (2004). Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Mol. Cell. Biol 5, 647657.
Burns, S., Thrasher, A. J., Blundell, M. P., Machesky, L., Jones, G. E. (2001). Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 98, 11421149.
Destaing, O., Saltel, F., Geminard, J. C., Jurdic, P., Bard, F. (2003). Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol. Biol. Cell 14, 407416.
Destaing, O., Saltel, F., Gillquin, B., Chabadel, A., Khochbin, S., Ory, S., Jurdic, P. (2005). A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J. Cell Sci 118, 29012911.
Dorner, C., Ciossek, T., Müller, S., Møller, N., Ullrich, A., Lammers, R. (1998). Characterization of KIF1C, a new kinesin-like protein involved in vesicle transport from the Golgi apparatus to the endoplasmic reticulum. J. Biol. Chem 273, 2026720275.
Dorner, C., Ullrich, A., Häring, H., Lammers, R. (1999). The kinesin-like motor protein KIF1C occurs in intact cells as a dimer and associates with proteins of the 14-3-3 family. J. Biol. Chem 274, 3365433660.
Evans, J., Correia, I., Krasavina, O., Watson, N., Matsudaira, P. (2003). Macrophage podosomes assemble at the leading lamella by growth and fragmentation. J. Cell Biol 161, 697705.
Galjart, N. (2005). CLIPs and CLASPs and cellular dynamics. Nat. Rev. Mol. Cell. Biol 6, 487498.[CrossRef][Medline]
Gavazzi, I., Nermut, M. V., Marchisio, P. C. (1989). Ultrastructure and gold-immunolabelling of cell-substratum adhesions (podosomes) in RSV-transformed BHK cells. J. Cell Sci 94, 8599.
Goode, B., Drubin, D., Barnes, G. (2000). Functional cooperation between the microtubule and actin cytoskeletons. Curr. Opin. Cell Biol 12, 6371.[CrossRef][Medline]
Gundersen, G. G., Gomes, E. R., Wen, Y. (2004). Cortical control of microtubule stability and polarization. Curr. Opin. Cell Biol 16, 106112.[CrossRef][Medline]
Honegger, A. M., Dull, T. J., Felder, S., Van Obberghen, E., Bellot, F., Szapary, D., Schmidt, A., Ullrich, A., Schlessinger, J. (1987). Point mutation in the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell 51, 199209.[CrossRef][Medline]
Huang, J., Brady, S., Richards, B., Stenoien, D., Resau, J., Copeland, N., Jenkins, N. (1999). Direct interaction of microtubule- and actin-based transport motors. Nature 397, 267270.[CrossRef][Medline]
Ingold, A. L., Cohn, S., Scholey, J. (1988). Inhibition of kinesin-driven microtubule motility by monoclonal antibodies to kinesin heavy chains. J. Cell Biol 107, 26572667.
Kanehisa, J., Yamanaka, T., Dio, S., Turksen, K., Heersche, J., Aubin, F., Takeuchi, H. (1990). A band of F-actin containing podosomes is involved in bone resorption by osteoclasts. Bone 11, 287293.[Medline]
Kaverina, I., Krylyshkina, O., Small, J. (1999). Microtubule targeting of substrate contacts promotes their relaxation and dissociation. J. Cell Biol 146, 10331043.
Kaverina, I., Krylyshkina, O., Small, J. (2002). Regulation of substrate adhesion dynamics during cell motility. Int. J. Biochem. Cell Biol 34, 746761.[CrossRef][Medline]
Krylyshkina, O., Anderson, K., Kaverina, I., Upmann, I., Manstein, D., Small, J., Toomre, D. (2003). Nanometer targeting of microtubules to focal adhesions. J. Cell Biol 161, 853859.
Krylyshkina, O., Kaverina, I., Kranewitter, W., Steffen, W., Alonso, M., Cross, R., Small, J. (2002). Modulation of substrate adhesion dynamics via microtubule targeting requires kinesin-1. J. Cell Biol 156, 349359.
Lawrence, C. J., et al. (2004). A standardized kinesin nomenclature. J. Cell Biol 167, 1922.
Limouze, J., Straight, A. F., Mitchison, T., Sellers, J. F. (2004). Specificity of blebbistatin, an inhibitor of myosin II. J. Muscle Res. Cell Motil 25, 337341.[CrossRef][Medline]
Linder, S. and Aepfelbacher, M. (2003). Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 13, 376385.[CrossRef][Medline]
Linder, S., Hufner, K., Wintergerst, U., Aepfelbacher, M. (2000). Microtubule-dependent formation of podosomal adhesion structures in primary human macrophages. J. Cell Sci 113, 41654176.[Abstract]
Linder, S. and Kopp, P. (2005). Podosomes at a glance. J. Cell Sci 118, 20792082.
Linder, S., Nelson, D., Weiss, M., Aepfelbacher, M. (1999). Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc. Natl. Acad. Sci. USA 96, 96489653.
Louie, R. K., Bahmanyar, S., Siemers, K. A., Votin, V., Chang, P., Stearns, T., Nelson, W. J., Barth, A. I. (2004). Adenomatous polyposis coli and EB1 localize in close proximity of the mother centriole and EB1 is a functional component of centrosomes. J. Cell Sci 117, 11171128.
Machuy, N., Thiede, B., Rajalingam, K., Dimmler, C., Thieck, O., Meyer, T. F., Rudel, T. (2005). A global approach combining proteome analysis and phenotypic screening with RNA interference yields novel apoptosis regulators. Mol. Cell Proteomics 4, 4455.
Marchisio, P. C., D'Urso, N., Comoglio, P. M., Giancotti, F. G., Tarone, G. (1988). Vanadate-treated baby hamster kidney fibroblasts show cytoskeleton and adhesion patterns similar to their Rous sarcoma virus-transformed counterparts. J. Cell. Biochem 37, 151159.[CrossRef][Medline]
Miki, H., Setou, M., Kaneshiro, K., Hirokawa, N. (2001). All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl. Acad. Sci. USA 98, 70047011.
Morris, R. and Scholey, J. (1997). Heterotrimeric Kinesin-II is required for the assembly of motile 9+2 ciliary axonemes on sea urchin embryos. J. Cell Biol 138, 10091022.
Nakajima, K., Takei, Y., Tanaka, Y., Nakagawa, T., Nakata, T., Noda, Y., Setou, M., Hirokawa, N. (2002). Molecular motor KIF1C is not essential for mouse survival and motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport. Mol. Cell. Biol 22, 866873.
Nakata, T. and Hirokawa, N. (1995). Point mutation of adenosine triphosphate-binding motif generated rigor kinesin that selectively blocks anterograde lysosome membrane transport. J. Cell Biol 131, 10391053.
Osiak, A.-E., Zenner, G., Linder, S. (2005). Subconfluent endothelial cells form podosomes downstream of cytokine and RhoGTPase signaling. Exp. Cell Res 307, 342353.[CrossRef][Medline]
Rodriguez, O. C., Schaefer, A., Mandato, C., Forscher, P., Bement, W., Waterman-Storer, C. (2003). Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat. Cell Biol 5, 599609.[CrossRef][Medline]
Sack, S., Kull, F. J., Mandelkow, E. (1999). Motor proteins of the kinesin family. Structures, variations, and nucleotide binding sites. Eur. J. Biochem 262, 111.
Salmon, W. C., Adams, M. C., Waterman-Storer, C. M. (2002). Dual-wavelength fluorescent speckle microscopy reveals coupling of microtubule and actin movements in migrating cells. J. Cell Biol 158, 3137.
Schliwa, M., Ezzell, R. M., Euteneuer, U. (1984). erythro-9-[3-(2-Hydroxynonyl)]adenine is an effective inhibitor of cell motility and actin assembly. Proc. Natl. Acad. Sci. USA 81, 60446048.
Schliwa, M. and Woehlke, G. (2003). Molecular motors. Nature 422, 759765.